KELLY NASTASI: Open Payments
NPI 1912475773 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 9 payments from 8 companies in 2025. Trend: 2023 $609 · 2024 $569 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $139 |
| Galderma Laboratories, L.P. | 1 | $125 |
| Exact Sciences Corporation | 1 | $97 |
| Novo Nordisk Inc | 2 | $38 |
| Dexcom, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: LEQVIO, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter, Ozempic, BREZTRI, UBRELVY, JARDIANCE, Rybelsus.
Industry payments across LA — which companies pay providers there.
